Step two: if it is listed, your prescriber will need to submit a prior authorization showing you meet criteria (typically BMI 30+ or BMI 27+ with a comorbidity, documented in your medical record)
However, repeated missed doses may reduce appetite suppression and metabolic benefits over time, requiring provider reassessment
The dual action of Tirzepatide effectively reduces caloric intake while improving glucose metabolism, which explains why the SURMOUNT-1 trial data showed up to a 22.5% mean weight reduction at the 72-week mark
In a randomized, double-blind, breast cancer prevention trial (NSABP P-1 trial), constipation (4.4% vs 3.2%) occurred more often in women at high risk for developing breast cancer who received 5 years of tamoxifen therapy (n = 6492) compared with placebo (n = 6484)
There is no strong evidence that semaglutide directly affects liver function tests
J.MarquesJ